Request for Proposals - Supply of a CDK4/CDK6 Inhibitor for the Treatment of HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Published 03 May 2020
New Zealand
Pharmaceutical Management Agency
Request for Proposals - Supply of a CDK4/CDK6 Inhibitor for the Treatment of HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Pharmaceutical Management Agency
Contract award

Contract details

Awarded
REQUEST FOR PROPOSALS - SUPPLY OF A CDK4/CDK6 INHIBITOR FOR THE TREATMENT OF HR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER PHARMAC invites proposals for the supply of a CDK4/CDK6 inhibitor for the treatment of HR-positive, HER2-negative locally advance…

Create an account to view the complete contract overview and award information.

Awarded suppliers

View awarded suppliers

Upgrade to Pro to identify the organisations awarded this contract and access their supplier profiles.

Similar opportunities

Finding tenders with similar work types, categories, locations, or project scope.

Find contract opportunities.
Win more tenders.

Live tenders, past award data and procurement intelligence — designed to help you win more business.